CGA
NVO

Compound Global Advisors’s Novo Nordisk NVO Stock Holding History

Compound Global Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.9K Buy
+1,500
New +$64.4K 1.78% 19
2024
Q1 		$6.7M Sell
52,169
-7,536
-13% -$897K 1% 29
2023
Q4 		$6.18M Buy
59,705
+17,017
+40% +$1.68M 1.14% 32
2023
Q3 		$3.88M Buy
+42,688
New +$3.76M 0.85% 34

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Compound Global Advisors's NVO Position: Q2 2026 in Review

Compound Global Advisors opened a new position in Novo Nordisk (NVO) in Q2 2026: 1,500 shares worth $71.9K. The stake represents 1.78% of the portfolio and ranks #19 among its holdings. This is a return to the name: Compound Global Advisors previously reported a position in NVO as recently as Q1 2024.

Compound Global Advisors first reported a position in NVO in Q3 2023 and has held it in 4 quarters since. The position peaked at $6.7M in Q1 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Compound Global Advisors held 1,500 shares of Novo Nordisk worth $71.9K as of Q2 2026.
  • Novo Nordisk was a new Compound Global Advisors position in Q2 2026.
  • Novo Nordisk made up 1.78% of Compound Global Advisors's portfolio in Q2 2026, its #19 holding.
  • Compound Global Advisors first reported a position in Novo Nordisk in Q3 2023 and has held it in 4 quarters since.
  • Compound Global Advisors's Novo Nordisk position peaked at $6.7M in Q1 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Compound Global Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.